BM
Bristol-Myers Squibb Company PFD CONV 2
BMYMP · OTC
$400.00 -57.46% (-$540.22)
Market Cap $814.6B
P/E Ratio 115.94x
Div. Yield 0.38%
ROE 25.85%
Bulios Fair Price
$555.38
38.8% upside
Trenutna cena
$400
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica BMYMP trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
7/9Valuation
0 /100
Expensive P/E 115.94x
P/FCF 53.23x
EV/EBITDA 54.94x
Growth
79 /100
Growing EPS growth 13.64%
Book val. growth 15.56%
Rev. growth 20.86%
Profitability
97 /100
Strong Gross margin 63.15%
FCF margin 31.75%
Net margin 14.64%
Quality
100 /100
Excellent ROIC 90.34%
Asset turnover 4.52x
ROE 25.85%
Debt
47 /100
Moderate Debt/Equity -0.81x
Net debt/EBITDA -4.00x
Current ratio -4.72x
Stability
11 /100
Unstable Beta 0.27x
Profitable years 0
Rev. volatility 34.01%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BMYMP
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Christopher S. Boerner
Employees
34,100
Headquarters
Princeton